mRNA Profiling and Transcriptomics Analysis of Chickens Received Newcastle Disease Virus Genotype II and Genotype VII Vaccines
Pathogens · 30.07.2024 · 13 (8) · 638
DOI: 10.3390/pathogens13080638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 30.07.2024. Verfasst von Putri Pandarangga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departemen Klinik, Reproduksi, dan Patologi, Fakultas Kedokteran dan Kedokteran Hewan, Universitas Nusa Cendana, Kupang 85001, Indonesia. Hauptthemen laut MEDLINE: Newcastle disease virus, Chickens, Newcastle Disease, Viral Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Centre for International Agricultural Research.
Abstract (Originalsprache)
Newcastle Disease Virus (NDV) genotype VII (GVII) is becoming the predominant strain of NDV in the poultry industry. It causes high mortality even in vaccinated chickens with a common NDV genotype II vaccine (GII-vacc). To overcome this, the killed GVII vaccine has been used to prevent NDV outbreaks. However, the debate about vaccine differences remains ongoing. Hence, this study investigated the difference in chickens’ responses to the two vaccines at the molecular level. The spleen transcriptomes from vaccinated chickens reveal that GVII-vacc affected the immune response by downregulating neuroinflammation. It also enhanced a synaptogenesis pathway that operates typically in the nervous system, suggesting a mechanism for the neurotrophic effect of this strain. We speculated that the down-regulated immune system regulation correlated with protecting the nervous system from excess leukocytes and cytokine activity. In contrast, GII-vacc inhibited apoptosis by downregulating PERK/ATF4/CHOP as part of the unfolded protein response pathway but did not affect the expression of the same synaptogenesis pathway. Thus, the application of GVII-vacc needs to be considered in countries where GVII is the leading cause of NDV outbreaks. The predicted molecular signatures may also be used in developing new vaccines that trigger specific genes in the immune system in combating NDV outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departemen Klinik, Reproduksi, dan Patologi, Fakultas Kedokteran dan Kedokteran Hewan, Universitas Nusa Cendana, Kupang 85001, Indonesia.
- School of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.
- Department of Veterinary Medicine, Tay Nguyen University, Buon Ma Thuot 630000, Vietnam.
- Davies Research Centre, School of Animal and Veterinary Sciences, University of Adelaide, Adelaide 5371, Australia.
- National Research and Innovation Agency, Jakarta 10340, Indonesia.
ORCID-Profile: Putri Pandarangga, Phuong Thi Kim Doan, Wai Yee Low, Yan Ren, Farhid Hemmatzadeh
Förderung
- Australian Centre for International Agricultural Research
Zitieren
APA
Pandarangga, P., Doan, P. T. K., Tearle, R., Low, W. Y., Ren, Y., Nguyen, H. T. H., Dharmayanti, N. I., & Hemmatzadeh, F. (2024). mRNA Profiling and Transcriptomics Analysis of Chickens Received Newcastle Disease Virus Genotype II and Genotype VII Vaccines. Pathogens, 13(8), 638. https://doi.org/10.3390/pathogens13080638
Vancouver
Pandarangga P, Doan PTK, Tearle R, Low WY, Ren Y, Nguyen HTH, et al. mRNA Profiling and Transcriptomics Analysis of Chickens Received Newcastle Disease Virus Genotype II and Genotype VII Vaccines. Pathogens. 2024;13(8):638. doi:10.3390/pathogens13080638
BibTeX
@article{Pandarangga2024,
author = {Pandarangga, Putri and Doan, Phuong Thi Kim and Tearle, Rick and Low, Wai Yee and Ren, Yan and Nguyen, Hanh Thi Hong and Dharmayanti, Niluh Indi and Hemmatzadeh, Farhid},
title = {mRNA Profiling and Transcriptomics Analysis of Chickens Received Newcastle Disease Virus Genotype II and Genotype VII Vaccines},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {8},
pages = {638},
doi = {10.3390/pathogens13080638}
}
EUVIMED